Comorbidities as risk factors for clinical outcomes in pediatric patients with COVID-19: a comprehensive literature review
Main Article Content
Keywords
Comorbidities, risk factors, COVID-19, paediatric
Abstract
Background: The population that in a high risk to have a svere COVID-19 infection is children. The difficulties can influence the risk of controlling their hygiene and be worsened by the immaturity immune system, especially in children with comorbidities. Moreover, this problem needs to be prioritized in children. Despite in worldwide spread of severe COVID-19 infection, there are limited data regarding severe COVID-19 disease in children. Thus, we investigated the effects of comorbidities as risk factors for clinical outcomes in paediatric patients with COVID-19.
Methods: This comprehensive literature review was from the PubMed, Google Scholar, and Science Direct databases through January 2021. The keywords used to obtain the literature include “COVID-19”, “coronavirus”, ” pediatric”, ”children”, ”severity”, ”comorbidity”, ”mortality”, ”death,” and “intensive”. The article with the inclusion criteria was involved. The information about the COVID-19 severity and underlying comorbidities in children were the main criteria that were enrolled.
Results: The severe clinical risk factors in paediatric patients with COVID-19 that are reported most often are chronic lung disease (including asthma) (4312 critical patients), obesity (1007 critical patients), diabetes mellitus (815 patients), cardiovascular disorders (677 patients) and neurological disorders (542), prematurity (183 patients) and immunosuppression conditions including malignancy (143 patients). Other conditions in the form of hematological disorders, airway abnormalities, malnutrition and gastrointestinal disorders can also contribute to the clinical severity of paediatric COVID-19 patients.
Conclusion: Children with underlying diseases such as obesity, chronic lung disease, cardiovascular disease, and neurologic disease had a higher risk of severe COVID-19 than children without comorbidities.
References
2. Williams SN, Armitage CJ, Tampe T, Dienes K. Public perceptions and experiences of social distancing and social isolation during the COVID-19 pandemic: A UK-based focus group study. BMJ Open. 2020;10(7):1–8.
3. Ladhani SN, Andrews N, Parikh SR, Campbell H, White J, Edelstein M, et al. Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in England. N Engl J Med. 2020;382(4):309–17.
4. Alsohime F, Temsah MH, Al-Nemri AM, Somily AM, Al-Subaie S. COVID-19 infection prevalence in pediatric population: Etiology, clinical presentation, and outcome. J Infect Public Health. 2020;13(12):1791–6.
5. Gudbjartsson DF, Helgason A, Jonsson H, Magnusson OT, Melsted P, Norddahl GL, et al. Spread of SARS-CoV-2 in the Icelandic Population. N Engl J Med. 2020;382(24):2302–15.
6. Morin S, Lallemant M, Garcia-Prats A, Lewis L, Watkins M, Giaquinto C, et al. Pediatric COVID-19 Therapeutics: Seizing the Right Research and Development Opportunities to Accelerate Access for Children. Pediatr Infect Dis J. 2022;41(1):e1–5.
7. Harwood R, Yan H, Talawila Da Camara N, Smith C, Ward J, Tudur-Smith C, et al. Which children and young people are at higher risk of severe disease and death after hospitalisation with SARS-CoV-2 infection in children and young people: A systematic review and individual patient meta-analysis. EClinicalMedicine. 2022;44:101287.
8. Piccini B, Pessina B, Pezzoli F, Casalini E, Toni S. COVID-19 vaccination in adolescents and young adults with type 1 diabetes: Glycemic control and side effects. Pediatr Diabetes. 2022;23(4):469–72.
9. González-Dambrauskas S, Vásquez-Hoyos P, Camporesi A, Díaz-Rubio F, Piñeres-Olave BE, Fernández-Sarmiento J, et al. Pediatric Critical Care and COVID-19. Pediatrics. 2020;146(3).
10. Woodruff RC, Campbell AP, Taylor CA, Chai SJ, Kawasaki B, Meek J, et al. Risk Factors for Severe COVID-19 in Children. Pediatrics. 2022;149(1).
11. Kara AA, Böncüoğlu E, Kıymet E, Arıkan KÖ, Şahinkaya Ş, Düzgöl M, et al. Evaluation of predictors of severe-moderate COVID-19 infections at children: A review of 292 children. J Med Virol. 2021;93(12):6634–40.
12. Verma S, Lumba R, Dapul HM, Gold-von Simson G, Phoon CK, Lighter JL, et al. Characteristics of Hospitalized Children With SARS-CoV-2 in the New York City Metropolitan Area. Hosp Pediatr. 2021;11(1):71–8.
13. Graff K, Smith C, Silveira L, Jung S, Curran-Hays S, Jarjour J, et al. Risk Factors for Severe COVID-19 in Children. Pediatr Infect Dis J. 2021;40(4):e137–45.
14. Swann O V., Holden KA, Turtle L, Pollock L, Fairfield CJ, Drake TM, et al. Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: Prospective multicentre observational cohort study. BMJ. 2020;370.
15. Leeb RT, Price S, Sliwa S, Kimball A, Szucs L, Caruso E, et al. COVID-19 trends among school-aged children — United States. Morb Mortal Wkly Rep. 2020;69(39):1410–5.
16. Shekerdemian LS, Mahmood NR, Wolfe KK, Riggs BJ, Ross CE, McKiernan CA, et al. Characteristics and outcomes of children with coronavirus disease 2019 (COVID-19) infection admitted to US and Canadian pediatric intensive care units. JAMA Pediatr. 2020;174(9):868–73.
17. DeBiasi RL, Song X, Delaney M, Bell M, Smith K, Pershad J, et al. Severe Coronavirus Disease-2019 in Children and Young Adults in the Washington, DC, Metropolitan Region. Vol. 223, The Journal of pediatrics. United States; 2020. p. 199-203.e1.
18. Zachariah P, Johnson CL, Halabi KC, Ahn D, Sen AI, Fischer A, et al. Epidemiology, Clinical Features, and Disease Severity in Patients With Coronavirus Disease 2019 (COVID-19) in a Children’s Hospital in New York City, New York. JAMA Pediatr. 2020;174(10):e202430.
19. Fernandes DM, Oliveira CR, Guerguis S, Eisenberg R, Choi J, Kim M, et al. Severe Acute Respiratory Syndrome Coronavirus 2 Clinical Syndromes and Predictors of Disease Severity in Hospitalized Children and Youth. J Pediatr. 2021;230:23-31.e10.
20. Kompaniyets L, Agathis NT, Nelson JM, Preston LE, Ko JY, Belay B, et al. Underlying Medical Conditions Associated With Severe COVID-19 Illness Among Children. JAMA Netw open. 2021;4(6):e2111182.
21. Götzinger F, Santiago-García B, Noguera-Julián A, Lanaspa M, Lancella L, Calò Carducci FI, et al. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. Lancet Child Adolesc Heal. 2020;4(9):653–61.
22. Harman K, Verma A, Cook J, Radia T, Zuckerman M, Deep A, et al. Ethnicity and COVID-19 in children with comorbidities. Vol. 4, The Lancet. Child & adolescent health. England; 2020. p. e24–5.
23. Sun D, Li H, Lu XX, Xiao H, Ren J, Zhang FR, et al. Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center’s observational study. World J Pediatr. 2020;16(3):251–9.
24. Zheng Y-Y, Ma Y-T, Zhang J-Y, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):259–60.
25. Nicastro E, Verdoni L, Bettini LR, Zuin G, Balduzzi A, Montini G, et al. COVID-19 in Immunosuppressed Children. Front Pediatr. 2021;9:629240.
26. Castro-Rodriguez JA, Forno E. Asthma and COVID-19 in children: A systematic review and call for data. Pediatr Pulmonol. 2020;55(9):2412–8.
27. Gasmi A, Peana M, Pivina L, Srinath S, Gasmi Benahmed A, Semenova Y, et al. Interrelations between COVID-19 and other disorders. Clin Immunol. 2021;224:108651.
28. Lim S, Bae JH, Kwon H-S, Nauck MA. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol. 2021;17(1):11–30.
29. Soleimani A, Soleimani Z. Presentation and Outcome of Congenital Heart Disease During Covid-19 Pandemic: A Review. Curr Probl Cardiol. 2022;47(1):100905.
30. Alsaied T, Aboulhosn JA, Cotts TB, Daniels CJ, Etheridge SP, Feltes TF, et al. Coronavirus Disease 2019 (COVID-19) Pandemic Implications in Pediatric and Adult Congenital Heart Disease. J Am Heart Assoc. 2020;9(12):e017224.
31. Brandenburg JE, Fogarty MJ, Sieck GC. Why individuals with cerebral palsy are at higher risk for respiratory complications from COVID-19. J Pediatr Rehabil Med. 2020;13(3):317–27.
32. Millet GP, Debevec T, Brocherie F, Burtscher M, Burtscher J. Altitude and COVID-19: Friend or foe? A narrative review. Physiol Rep. 2021;8(24):e14615.